Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Duyster

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Blood|August 25, 2001
Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosisH van der Kuip, A W Goetz, C Miething, et al.
Leukemia|March 16, 2002
Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27T Decker, F Schneller, S Hipp, et al.
Leukemia|February 19, 2011
In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host diseaseN Hartmann, F Leithäuser, C Albers, et al.
Leukemia|September 13, 2003
Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivoC Miething, C Mugler, R Grundler, et al.
Leukemia|September 25, 2014
Grb10 is involved in BCR-ABL-positive leukemia in miceA L Illert, C Albers, S Kreutmair, et al.
Leukemia|April 6, 2016
Lineage-specific STAT5 target gene activation in hematopoietic progenitor cells predicts the FLT3(+)-mediated leukemic phenotypeT A Müller, R Grundler, R Istvanffy, et al.
Experimental Hematology|January 21, 2000
The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulationG Hübinger, I Scheffrahn, E Müller, et al.
Leukemia|February 17, 2006
The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinibC Miething, S Feihl, C Mugler, et al.
Oncogene|March 26, 2008
Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cellsS Fanta, M Sonnenberg, I Skorta, et al.
Oncogene|September 25, 1998
The SH2-containing adapter protein GRB10 interacts with BCR-ABLR Y Bai, T Jahn, S Schrem, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Blood|August 25, 2001
Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosisH van der Kuip, A W Goetz, C Miething, et al.
Leukemia|March 16, 2002
Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27T Decker, F Schneller, S Hipp, et al.
Leukemia|February 19, 2011
In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host diseaseN Hartmann, F Leithäuser, C Albers, et al.
Leukemia|September 13, 2003
Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivoC Miething, C Mugler, R Grundler, et al.
Leukemia|September 25, 2014
Grb10 is involved in BCR-ABL-positive leukemia in miceA L Illert, C Albers, S Kreutmair, et al.
Leukemia|April 6, 2016
Lineage-specific STAT5 target gene activation in hematopoietic progenitor cells predicts the FLT3(+)-mediated leukemic phenotypeT A Müller, R Grundler, R Istvanffy, et al.
Experimental Hematology|January 21, 2000
The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulationG Hübinger, I Scheffrahn, E Müller, et al.
Leukemia|February 17, 2006
The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinibC Miething, S Feihl, C Mugler, et al.
Oncogene|March 26, 2008
Pharmacological inhibition of c-Abl compromises genetic stability and DNA repair in Bcr-Abl-negative cellsS Fanta, M Sonnenberg, I Skorta, et al.
Oncogene|September 25, 1998
The SH2-containing adapter protein GRB10 interacts with BCR-ABLR Y Bai, T Jahn, S Schrem, et al.
Pageof 6